Literature DB >> 22260350

Immunostaining for mismatch repair (MMR) protein expression in colorectal cancer is better and easier to interpret when performed on diagnostic biopsies.

Wakkas Fadhil, Mohammad Ilyas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22260350     DOI： 10.1111/j.1365-2559.2011.04021.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

1.  Molecular classification and precision therapy of cancer: immune checkpoint inhibitors.

Authors:  Yingyan Yu
Journal:  Front Med       Date:  2017-12-05       Impact factor: 4.592

2.  Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis.

Authors:  K T S Aiyer; T Doeleman; N A Ryan; M Nielsen; E J Crosbie; V T H B M Smit; H Morreau; J J Goeman; T Bosse
Journal:  Mod Pathol       Date:  2022-09-14       Impact factor: 8.209

Review 3.  Deficient mismatch repair: Read all about it (Review).

Authors:  Susan Richman
Journal:  Int J Oncol       Date:  2015-08-12       Impact factor: 5.650

4.  Heterogenous mismatch-repair status in colorectal cancer.

Authors:  Patrick Joost; Nynke Veurink; Susanne Holck; Louise Klarskov; Anders Bojesen; Maria Harbo; Bo Baldetorp; Eva Rambech; Mef Nilbert
Journal:  Diagn Pathol       Date:  2014-06-26       Impact factor: 2.644
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.